Advertisement

Telehealth

The Drug Enforcement Administration has extended the flexibilities that allow physicians to prescribe controlled substances via telemedicine without an in-person evaluation until November. 

Telehealth company Amwell has reported $389.5 million in losses, with an impairment charge contributing to the majority of that total, according to the company's first-quarter earnings posted May 3.

Advertisement